Incidence, persistence, and clearance of cervical human papillomavirus infection among gynecological outpatients in Kunming, Yunnan, China, 2019–2023: a retrospective cohort study
PeerJ · 2025
DOI: 10.7717/peerj.20215 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PeerJ, 2025. Verfasst von Yafei Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Papillomavirus Infections, Outpatients, Papillomaviridae. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Provincial Key Laboratory of Clinical Virology, Doctoral Program of the First People Hospital of Yunnan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Human papillomavirus (HPV), a leading sexually transmitted pathogen, is characterized by persistent infection, which represents a critical risk factor for cervical carcinogenesis. This retrospective cohort study investigated the epidemiology of HPV among 45,149 gynecological outpatients in Yunnan, China (2019–2023). The 12-month cumulative incidence of HPV infection was 36.84%, with the highest rates observed in the 30–49-year age group. HPV-52 was the predominant subtype, followed by HPV-51, -81, -58, and -16. Persistent infection was observed in 55.56% of cases, most frequently involving HPV-42, -52, -58, -81, and -56, with higher rates in individuals younger than 30 and older than 59 years. Overall clearance reached 74.43% and was inversely correlated with age. Rapid clearance was predominantly observed for HPV-26, -83, -11, -82, and -44, whereas high-risk HPV types (HPV-58, HPV-52, HPV-35) and low-risk types (HPV-42, HPV-81, HPV-43) exhibited prolonged persistence. Regional data indicate elevated risks of incident and persistent infections with HPV-58, HPV-52, HPV-42, and HPV-81, with older populations showing greater susceptibility to persistence and younger individuals demonstrating faster clearance. These findings underscore the age-specific dynamics of HPV infection and highlight priority subtypes for regional cervical cancer prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
- The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
- Medical School, Kunming University of Science and Technology, Kunming, Yunnan, China.
- Department of Gynaecology and Obstetrics, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
Förderung
- Yunnan Provincial Key Laboratory of Clinical Virology
- Doctoral Program of the First People Hospital of Yunnan Province
- National Natural Science Foundation of China
- Research Fund for the Doctoral Program of the First People Hospital of Yunnan Province
- The National Natural Science Foundation of China
Zitieren
APA
Huang, Y., Wei, X., Guo, Y., Su, T., Duan, Q., Fan, X., Wan, J., Zhang, Y., Zhang, G., Sun, Y., & Xu, Y. (2025). Incidence, persistence, and clearance of cervical human papillomavirus infection among gynecological outpatients in Kunming, Yunnan, China, 2019–2023: a retrospective cohort study. PeerJ. https://doi.org/10.7717/peerj.20215
Vancouver
Huang Y, Wei X, Guo Y, Su T, Duan Q, Fan X, et al. Incidence, persistence, and clearance of cervical human papillomavirus infection among gynecological outpatients in Kunming, Yunnan, China, 2019–2023: a retrospective cohort study. PeerJ. 2025. doi:10.7717/peerj.20215
BibTeX
@article{Huang2025,
author = {Huang, Yafei and Wei, Xiangcong and Guo, Yan and Su, Ting and Duan, Qiuting and Fan, Xin and Wan, Jinxiu and Zhang, Yufan and Zhang, Guiqian and Sun, Yi and Xu, Ya},
title = {Incidence, persistence, and clearance of cervical human papillomavirus infection among gynecological outpatients in Kunming, Yunnan, China, 2019–2023: a retrospective cohort study},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.20215}
}
EUVIMED